Data shows medical marijuana use decreased in states where recreational use became legal 

Number of patients using cannabis for medical purposes has increased more than 600 percent since 2016

2:35 PM

marijuana leaf drawing blue lab note yellow badge upper left corner
Credit: Justine Ross, Jacob Dwyer/Michigan Medicine

The most recent data on medical cannabis use found that enrollment in medical cannabis programs increased overall between 2016 and 2022, but enrollment in states where nonmedical use of cannabis became legal saw a decrease in enrollment. 

Combined with the data from a previously published analysis, the number of patients using cannabis for medical purposes has increased more than 600 percent since 2016. The study is published in Annals of Internal Medicine.  

“These findings indicate the growing use of cannabis for medical purposes, but also that adult use laws may decrease rates of patient enrollment,” said Kevin Boehnke, Ph.D., a research assistant professor in the U-M Medical School Department of Anesthesiology and Chronic Pain & Fatigue Research Center.

Cannabis is legal for medical or nonmedical use in 38 and 23 states, respectively. However, it remains a schedule I substance under the Controlled Substances Act. This status has inhibited research on its health effects and disincentivized many physicians from pursuing education related to or treating patients who use cannabis. Recently, the Department of Health and Human Services recommended that cannabis be rescheduled to schedule III. Before this potential shift occurs, it is important to understand the current landscape of medical and nonmedical cannabis use and authorization.  

Researchers from University of Michigan Medical School and the Centers for Disease Control and Prevention conducted an ecological study with repeated measures of persons with medical cannabis licenses and clinicians authorizing cannabis licenses in the United States between 2020 and 2022. 

The authors included 39 jurisdictions (38 states and Washington, D.C.) that allowed for medical cannabis use in their analysis. Of these jurisdictions, 34 reported patient numbers, 19 reported patient-reported qualifying conditions, and 29 reported authorizing clinician numbers. They reported a 33 percent increase in enrollment in these jurisdictions between 2020 and 2022. 

The authors also included 15 jurisdictions with nonmedical adult-use laws. They found that in 13 of these 15 jurisdictions, medical enrollment decreased, and the proportion of patient-reported qualifying conditions with substantial or conclusive evidence of therapeutic value decreased from 70.4 to 53.8 percent. The most reported qualifying condition was chronic pain, followed by anxiety and post-traumatic stress disorder. 

The team notes that their findings highlight the need for better surveillance methods to adequately understand outcomes of medical cannabis use and thoughtful strategies and public health efforts to reduce harms from increased cannabis availability. 

Additional authors: Rachel Sinclair, B.Sc., Felicia Gordon, B.Sc., Avinash Hosanagar, M.D., Douglas R. Roehler, Ph.D., Tristin Smith, M.P.H., and Brooke Hoots, Ph.D.

Citation:Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022”. Annals of Internal Medicine, DOI: 10.7326/M23-28

Reposted from Annals of Internal Medicine

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week by subscribing to Health Lab’s two newsletters, Health & Wellness and Research & Innovation.

Sign up for the Health Lab Podcast: Add us on SpotifyApple Podcasts or wherever you get you listen to your favorite shows.


More Articles About: medical marijuana Behavioral Health Demographics Health Care Delivery, Policy and Economics Mental Health Pain management
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Related
RX Bottle
Health Lab
What Drives Patients to Use Medical Marijuana: Mostly Chronic Pain
New study seeks to understand whether people are using cannabis for evidence-based reasons
Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories zoom screens with 7 different backgrounds and doctor silhouettes outlined in each
Health Lab
The doctor is in…. but what’s behind them?
A study reveals that what a doctor has behind them during a telehealth visit can make a difference in how the patient feels about them and their care.
mushrooms in a microscope
Health Lab
How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic pain
Recent developments represent a dramatic change from long standing federal policy around these substances that has historically criminalized their use and blocked or delayed research efforts into their therapeutic potential.
doctor in white coat with dark blue scrubs touching hand of patient in grey sweater and baseball cap in exam room
Health Lab
Neuropathy common, and mostly undiagnosed, among patients in this Michigan city
A research team, led by Michigan Medicine and in partnership with Hurley Medical Center, finds that nearly three-quarters of patients at a clinic in Flint, Mich., a community that is predominantly Black and socioeconomically disadvantaged, had neuropathy — of which 75% was undiagnosed.
cancer cell blue yellow
Health Lab
Widening inequality seen where cancer clinical trials are available
The availability of clinical trials of new treatments for cancer varies greatly by geography, and a new study shows more socially vulnerable areas have far fewer.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Treating Diabetes & Weight: The Ozempic & Wegovy Effect
Today on The Fundamentals, our guest Dr. Martin Myers, Director of the U-M Elizabeth Weiser Caswell Diabetes Institute, discusses diabetes research in the context of Ozempic, Wegovy, and other drugs that are changing how people think about weight loss. You can learn more about Dr. Myers here, and you can follow the department of molecular and integrative physiology @UMPhysiology on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.